Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $267.75 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $79.43 | 4 | $0 (2024) |
| Lilly USA, LLC | $58.07 | 4 | $0 (2024) |
| Corcept Therapeutics | $37.00 | 2 | $0 (2024) |
| Genentech USA, Inc. | $25.41 | 8 | $0 (2021) |
| Novo Nordisk Inc | $22.63 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $16.32 | 1 | $0 (2024) |
| PFIZER INC. | $14.84 | 1 | $0 (2024) |
| VBI Vaccines (Delaware) Inc. | $14.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.80 | 9 | Otsuka America Pharmaceutical, Inc. ($59.11) |
| 2023 | $47.10 | 3 | Lilly USA, LLC ($26.78) |
| 2022 | $14.05 | 1 | VBI Vaccines (Delaware) Inc. ($14.05) |
| 2021 | $40.80 | 9 | Genentech USA, Inc. ($25.41) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: VACCINE | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.63 | General |
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Diabetes | ||||||
| 04/05/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 12/06/2022 | VBI Vaccines (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: VACCINE | ||||||
| 12/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: Virology & Specialty Care | ||||||
| 10/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Virology & Specialty Care | ||||||
| 03/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Virology & Specialty Care | ||||||
| 02/25/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: Virology & Specialty Care | ||||||
| 02/17/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Virology & Specialty Care | ||||||
| 02/10/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: Virology & Specialty Care | ||||||
| 02/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Virology & Specialty Care | ||||||
| 01/23/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 01/13/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 31 | $1,995 | $1,047 |
| 2022 | 6 | 104 | 118 | $4,811 | $1,793 |
| 2021 | 6 | 134 | 164 | $6,120 | $2,533 |
| 2020 | 6 | 173 | 211 | $7,980 | $3,355 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 14 | 16 | $1,440 | $804.48 | 55.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 15 | $555.00 | $243.00 | 43.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 14 | 14 | $700.00 | $453.97 | 64.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 14 | 24 | $514.00 | $377.18 | 73.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 21 | 21 | $741.00 | $343.63 | 46.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 20 | 22 | $1,430 | $230.09 | 16.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 12 | $551.00 | $195.92 | 35.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 23 | 25 | $875.00 | $192.41 | 22.0% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 25 | 50 | $1,000 | $827.50 | 82.8% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 35 | 37 | $1,295 | $611.61 | 47.2% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 14 | 14 | $700.00 | $494.62 | 70.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 25 | 26 | $1,690 | $274.56 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 22 | 23 | $805.00 | $178.71 | 22.2% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 13 | 14 | $630.00 | $146.16 | 23.2% |
| 87804 | Detection test for influenza virus | Office | 2020 | 30 | 59 | $1,180 | $972.49 | 82.4% |
| 87426 | Coronavirus ag ia | Office | 2020 | 24 | 24 | $1,200 | $812.59 | 67.7% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 46 | 48 | $1,680 | $791.46 | 47.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 29 | 33 | $2,145 | $337.71 | 15.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 31 | 34 | $1,190 | $256.25 | 21.5% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 13 | 13 | $585.00 | $184.25 | 31.5% |
About Leandra Smith
Leandra Smith is a Family healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2019. The National Provider Identifier (NPI) number assigned to this provider is 1154966703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leandra Smith has received a total of $267.75 in payments from pharmaceutical and medical device companies, with $165.80 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($267.75).
As a Medicare-enrolled provider, Smith has provided services to 438 Medicare beneficiaries, totaling 524 services with total Medicare billing of $8,729. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Hazard, KY
- Active Since 11/07/2019
- Last Updated 09/15/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154966703
Products in Payments
- Korlym (Drug) $37.00
- ABILIFY MAINTENA (Drug) $35.26
- TRULICITY (Drug) $29.39
- MOUNJARO (Drug) $28.68
- ABILIFY ASIMTUFII (Drug) $27.21
- Xofluza (Drug) $25.41
- REXULTI (Drug) $16.96
- GARDASIL (Biological) $16.32
- PREVNAR 20 (Biological) $14.84
- PreHevbrio (Drug) $14.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hazard
Paula Runyon, Aprn, APRN
Family — Payments: $4,858
Tracy Estridge, Aprn, APRN
Family — Payments: $4,431
Johnnie Watts, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $3,384
Jessica Ivey, Aprn, APRN
Family — Payments: $2,096
Megan Lewis, Aprn, APRN
Family — Payments: $2,029
Kathryn Morgan, Aprn, APRN
Family — Payments: $1,902